News

Judson Cooper, Lev’s chairman, said: “Our agreement to sell intermediate plasma products is consistent with our strategic plan to monetize this valuable asset for Lev and provides us

Results of the Phase III androgen deprivation therapy (ADT) clinical trial demonstrate that toremifene citrate 80mg compared to placebo built bone and prevented fractures, reduced hot flashes, and

The Fast trial will recruit a minimum of 30 patients from approximately five sites in the US. The study is scheduled to begin recruitment in April, 2008 and

Data from these studies showed that Xanafide (amonafide malate) triggered a similar level of apoptosis but with less DNA damage. While Xanafide targeted many of the same genes

Under the new agreement between LevTech, now a wholly-owned subsidiary of ATMI, and Sartorius Stedim, the LevTech disposable bag mixing system will be available through Sartorius Stedim as

This clinical trial is the second in a series of Phase II studies of ATX-101 in aesthetic applications and is aimed at assessing the safety and effectiveness of

The expansion builds on the success of the European collaborations in Cancer Research Program (CCRP), launched in April 2007. All of the researchers in the program are using

The product is currently approved and marketed in the UK, Italy, Spain, and Belgium. Eurand will make an up-front payment and commercial milestone payments to Chiesi Farmaceutici, primarily

This was the second of several regularly scheduled reviews by the data safety monitoring board (DSMB) that will occur over the duration of the trial. The purpose of